Physician profile
Obinna C Igwilo
NPI 1790954352
$7,531.78
in general payments reported to CMS, 2019-2025
8 companies · $1,993 in 2025
The $1,993 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,218 · 2020: $392 · 2022: $1,570 · 2023: $176 · 2024: $183 · 2025: $1,993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,302 · Food and Beverage: $954 · Consulting Fee: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,301.94 |
| Food and Beverage | $954.11 |
| Consulting Fee | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,621.11 | 2019-2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Intuitive Surgical, INC. | $1,838.49 | 2019-2020 | |
| Integra Lifesciences Corporation | $1,706.18 | 2022-2023 | Cytal |
| Genzyme Corporation | $157.69 | 2024 | |
| Medtronic, INC. | $95.00 | 2023-2025 | Endo Clip III, Eea |
| Acell, INC. | $86.51 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $15.09 | 2019 | |
| Glaxosmithkline, LLC. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Obinna Igwilo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.